Brainsway (BWAY) FCF Payout Ratio Growth (1y) (2020 - 2026)
Brainsway (BWAY) FCF Payout Ratio Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | -16.90% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | -8.00% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 0.45% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | -88.24% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | -11.29% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 27.54% |
| 10 | Brainsway | 571.60 Mn | 508.43 Mn | 12.77 Mn | 77.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 155.51% |
| Dec 31, 2025 | -313.37% |
| Sep 30, 2025 | 139.62% |
| Jun 30, 2025 | -77.01% |
| Mar 31, 2025 | 272.77% |
| Dec 31, 2024 | 335.17% |
| Sep 30, 2024 | -42.69% |
| Jun 30, 2024 | 25.88% |
| Mar 31, 2024 | 125.51% |
| Dec 31, 2023 | 116.91% |
| Sep 30, 2023 | 205.73% |
| Jun 30, 2023 | 176.56% |
| Mar 31, 2023 | -163.45% |
| Dec 31, 2022 | -134.55% |
| Sep 30, 2022 | 39.25% |
| Jun 30, 2022 | -85.84% |
| Mar 31, 2022 | 95.89% |
| Sep 30, 2021 | -1,045.20% |
| Jun 30, 2021 | -209.29% |
| Mar 31, 2021 | -943.38% |